Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Malonyl-CoA)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003768 AN006185 The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass Leaf Grass Hunan Agricultural University LC-MS
ST003768 AN006185 The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass Roots Grass Hunan Agricultural University LC-MS
ST003695 AN006063 Metabolomics studies on mouse cecum samples on a Western diet Cecum Mouse University of Sydney API-MS
ST003647 AN005992 Targeted mass spec-based metabolomic and clinical analyte analyses of liver and plasma samples from rats with and without hepatic knockdown of ChREBP expression. Liver Mouse Duke University LC-MS/MS(Dir. Inf.)
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Blood Mouse Cancer Wistar Institute LC-MS
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Brain Mouse Cancer Wistar Institute LC-MS
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Heart Mouse Cancer Wistar Institute LC-MS
ST003436 AN005645 Pharmacokinetics of Fasnall in NSG mice Liver Mouse Cancer Wistar Institute LC-MS
ST003436 AN005646 Pharmacokinetics of Fasnall in NSG mice Blood Mouse Cancer Wistar Institute LC-MS
ST003436 AN005646 Pharmacokinetics of Fasnall in NSG mice Brain Mouse Cancer Wistar Institute LC-MS
ST003436 AN005646 Pharmacokinetics of Fasnall in NSG mice Heart Mouse Cancer Wistar Institute LC-MS
ST003436 AN005646 Pharmacokinetics of Fasnall in NSG mice Liver Mouse Cancer Wistar Institute LC-MS
ST003435 AN005643 Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 Media Zebrafish Cancer Wistar Institute LC-MS
ST003435 AN005644 Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 Media Zebrafish Cancer Wistar Institute LC-MS
ST003434 AN005641 Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. Blood Mouse Cancer Wistar Institute LC-MS
ST003434 AN005642 Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. Blood Mouse Cancer Wistar Institute LC-MS
ST003433 AN005639 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 Cultured cells Human Cancer Wistar Institute LC-MS
ST003433 AN005640 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 Cultured cells Human Cancer Wistar Institute LC-MS
ST003432 AN005637 Intracellular and medium metabolomics of BT-474 cells treated with LW6 Cultured cells Human Cancer Wistar Institute LC-MS
ST003432 AN005638 Intracellular and medium metabolomics of BT-474 cells treated with LW6 Cultured cells Human Cancer Wistar Institute LC-MS
ST003431 AN005635 Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. Cultured cells Human Cancer Wistar Institute LC-MS
ST003431 AN005636 Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. Cultured cells Human Cancer Wistar Institute LC-MS
ST003430 AN005633 Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 Cultured cells Human Cancer Wistar Institute LC-MS
ST003430 AN005634 Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 Cultured cells Human Cancer Wistar Institute LC-MS
ST003429 AN005631 Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine Cultured cells Human Cancer Wistar Institute LC-MS
ST003429 AN005632 Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine Cultured cells Human Cancer Wistar Institute LC-MS
ST003428 AN005629 Intracellular and medium metabolomics of BT-474 cells treated with rotenone Cultured cells Human Cancer Wistar Institute LC-MS
ST003428 AN005630 Intracellular and medium metabolomics of BT-474 cells treated with rotenone Cultured cells Human Cancer Wistar Institute LC-MS
ST003427 AN005627 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate Breast cancer cells Human Cancer Wistar Institute LC-MS
ST003427 AN005628 Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate Breast cancer cells Human Cancer Wistar Institute LC-MS
ST003412 AN005604 Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h Cultured cells Human Cancer Wistar Institute LC-MS
ST003412 AN005605 Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h Cultured cells Human Cancer Wistar Institute LC-MS
ST003411 AN005602 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) Cultured cells Human Cancer Wistar Institute LC-MS
ST003411 AN005603 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) Cultured cells Human Cancer Wistar Institute LC-MS
ST003367 AN005518 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h Cultured cells Human Cancer Wistar Institute LC-MS
ST003367 AN005519 Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h Cultured cells Human Cancer Wistar Institute LC-MS
ST003366 AN005516 Malate dehydrogenase (MDH) inhibition assay: Fasnall does not affect MDH activity in vitro Synthetic Zebrafish Cancer Wistar Institute LC-MS
ST003366 AN005517 Malate dehydrogenase (MDH) inhibition assay: Fasnall does not affect MDH activity in vitro Synthetic Zebrafish Cancer Wistar Institute LC-MS
ST003365 AN005514 Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h Cultured cells Human Cancer Wistar Institute LC-MS
ST003365 AN005515 Intracellular and medium metabolomics for BT-474 breast cancer cells treated with a range of Fasnall and GSK2194069 concentrations for 24 h Cultured cells Human Cancer Wistar Institute LC-MS
ST003283 AN005378 Systematic evaluation of the hepatic de novo lipogenic substrate supply network reveals a hierarchical mitochondrial-cytosolic control structure Liver Mouse Metabolic syndrome University of Iowa LC-MS
ST003274 AN005361 Metabolomics analysis within healthy donors and end-stage heart failure with a focus on ischaemic cardiomyopathy with diabetes Heart Human Heart disease University of Sydney LC-MS
ST003253 AN005331 Metabolomics studies on mouse liver samples on a Western diet Liver Mouse Diabetes University of Sydney API-MS
ST003253 AN005331 Metabolomics studies on mouse liver samples on a Western diet Liver Mouse Hyperglycemia University of Sydney API-MS
ST003253 AN005331 Metabolomics studies on mouse liver samples on a Western diet Liver Mouse Hypertension University of Sydney API-MS
ST003253 AN005331 Metabolomics studies on mouse liver samples on a Western diet Liver Mouse Obesity University of Sydney API-MS
ST003252 AN005328 Metabolomics studies on mouse cardiac samples on a Western diet Heart Mouse Diabetes University of Sydney API-MS
ST003252 AN005328 Metabolomics studies on mouse cardiac samples on a Western diet Heart Mouse Hyperglycemia University of Sydney API-MS
ST003252 AN005328 Metabolomics studies on mouse cardiac samples on a Western diet Heart Mouse Hypertension University of Sydney API-MS
ST003252 AN005328 Metabolomics studies on mouse cardiac samples on a Western diet Heart Mouse Obesity University of Sydney API-MS
ST003148 AN005165 BT-474 cells fed with [U-13C6] D-glucose or [U-13C5] L-glutamine and treated with Fasnall and GSK2194069 for 24 h Cultured cells Human Cancer Wistar Institute LC-MS
ST003104 AN005083 Metabolomics studies on human cardiac samples Heart Human Heart disease University of Sydney API-MS
ST002936 AN004816 O-GlcNAcase activity maintains stress granules for proximity-enhanced ATP production to ensure recovery from stress (Part 2) Cultured cells Human Zhejiang University LC-MS
ST002922 AN004792 Effects of DINCH and MINCH on adipocyte metabolism of human SGBS cells. Adipose tissue Human Obesity Helmholtz Centre for Environmental Research LC-MS
ST002920 AN004790 Possible PPARG-independent effects of DINCH and MINCH on central carbon metabolism Adipose tissue Human Obesity Helmholtz Centre for Environmental Research LC-MS
ST002906 AN004769 Polar metabolite levels in K562 cells following short-term folate depletion Cultured cells Human Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002896 AN004755 Polar metabolite levels in MEL cells following folate depletion and inosine supplementation Cultured cells Mouse Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002895 AN004754 Polar metabolite levels in K562 cells following folate depletion and inosine supplementation Cultured cells Human Anemia Boston Children's Hospital, Harvard Medical School LC-MS
ST002865 AN004697 Metabolic profiling, glucose tracing and glutamine tracing in 16D prostate cancer cells treated with vehicle, AR inhibitor Enzalutamide, AR inhibitor Apalutamide, or AR degrader/PROTAC ARCC-4 Prostate cancer cells Human Cancer University of California, Los Angeles LC-MS
ST002864 AN004696 Metabolic profiling, glucose tracing and glutamine tracing in naive and Enzalutamide-treated 16D prostate cancer cells expressing RFP or MYC Prostate cancer cells Human Cancer University of California, Los Angeles LC-MS
ST002846 AN004664 Apolipoprotein E suppresses hyperlipidemia-driven hematopoiesis & inflammation by controlling mitochondrial metabolism Macrophages Mouse Hyperlipidemia Northwestern University LC-MS
ST002743 AN004448 Metabolomics comparison of lung fibroblasts from Pteropus alecto and Homo sapiens Cultured cells Black flying fox fruit bat Duke-NUS Medical School LC-MS
ST002743 AN004448 Metabolomics comparison of lung fibroblasts from Pteropus alecto and Homo sapiens Cultured cells Human Duke-NUS Medical School LC-MS
ST002717 AN004406 Ventricle-specific myocardial protein and metabolite characterisation in healthy humans, with differential regulation in end-stage cardiomyopathies (Part 2) Heart Human Cardiomyopathy University of Sydney LC-MS
ST002716 AN004404 Ventricle-specific myocardial protein and metabolite characterisation in healthy humans, with differential regulation in end-stage cardiomyopathies (Part 1) Heart Human Cardiomyopathy University of Sydney LC-MS
ST002708 AN004390 Levels of central carbon metabolites in choroid plexus as part of natural diurnal variation Brain Mouse Circadian Rhythm Disorder Boston Children's Hospital LC-MS
ST002584 AN004255 Metabolomics analysis of ALDH1L1-expressing HuH7 cell lines. Cultured cells Human Cancer Tohoku Medical and Pharmaceutical University LC-MS
ST002542 AN004188 Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 2) Yeast cells Saccharomyces cerevisiae ZheJiang University LC-MS
ST002542 AN004189 Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 2) Yeast cells Saccharomyces cerevisiae ZheJiang University LC-MS
ST002541 AN004186 Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 1) Yeast cells Saccharomyces cerevisiae Zhejiang University LC-MS
ST002541 AN004187 Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 1) Yeast cells Saccharomyces cerevisiae Zhejiang University LC-MS
ST002431 AN003957 MS profiling of the Long Term Evolution Experiment Bacterial cells Escherichia coli Rutgers University LC-MS
ST002431 AN003958 MS profiling of the Long Term Evolution Experiment Bacterial cells Escherichia coli Rutgers University LC-MS
ST002187 AN003581 Interplay of CodY and CcpA in regulating central metabolism and biofilm formation in S. aureus Bacterial cells Staphylococcus aureus Bacterial infection University of Nebraska Medical Center LC-MS
ST002152 AN003525 Metabolomics analysis of mouse liver with or without SIRT5 deficiency Liver Mouse North Carolina State University LC-MS
ST002123 AN003476 GCN2 regulates mitochondrial OXPHOS in HSPCs under proliferation conditions. Bone marrow Mouse Sun Yat-sen University LC-MS
ST002119 AN003469 Metabolomics analysis of zebrafish response to CID661578 treatment Larvae Zebrafish Diabetes North Carolina State University LC-MS
ST002084 AN003401 A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy(Part 2) Cultured cells Human Cancer Yale University LC-MS
ST001961 AN003196 Metabolomics of brown adipose tissue in murine heart failure model Adipose tissue Mouse Juntendo University MS(Dir. Inf.)
ST001441 AN002409 Metabolomics of patient-derived fibroblasts Fibroblast cells Human Mitochondrial disease North Carolina State University LC-MS
ST001364 AN002271 Core Functional Nodes and Sex-Specific Pathways in Human Ischemic and Dilated Cardiomyopathy Heart Human Cardiomyopathy University of Sydney API-MS
ST001350 AN002246 Extraction of high-resolution Metabolomics data of the Yeast Metabolic Cycle Yeast cells Saccharomyces cerevisiae University of Florida LC-MS
ST001135 AN001861 Different dose exposure of OPC-163493 on HepG2 cells (part-I) Hep G2 cells Human Diabetes Otsuka Pharmaceutical Co., Ltd. LC-MS
ST000451 AN000707 The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data Muscle Mouse University of North Carolina at Chapel Hill GC-MS
ST000351 AN000571 Determining the metabolic profile of wildtype, lrgAB, and atlA mutant Steptococcus mutans grown aerobically and anaerobically Bacterial cells Streptococcus mutans Antibiotic resistance University of Florida LC-MS
ST000337 AN000545 Metabolomics Approach to Allograft Assessment in Liver Transplantation Liver Human Organ transplantation Ochsner Multi-Organ Transplant Institute LC-MS
ST000282 AN000449 Pilot Study 13C flux effects when RhoC or RhoA perturbed (13C BCs) Cells Human University of Michigan GC-MS/LC-MS
ST000159 AN000251 U13C-Glutamine and U13C-Glucose Flux Analysis (MFA SiHa B16F10) Cultured cells Human University of Michigan LC-MS
ST000154 AN000245 Use of Aspartate Dehydrogenase by cancer cells T-cells Human University of Michigan GC-MS/LC-MS
ST000147 AN000233 13C targeted metabolomics T-cells Human University of Michigan GC-MS/LC-MS
ST000146 AN000232 Noxa regulation of malate aspartate shuttle T-cells Human Cancer University of Michigan LC-MS
ST000145 AN000230 Primary T Cell Noxa Knockdown (Donor 8) T-cells Human Cancer University of Michigan GC-MS/LC-MS
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Adipose tissue Mouse University of Michigan LC-MS
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Blood Mouse University of Michigan LC-MS
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Heart Mouse University of Michigan LC-MS
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Liver Mouse University of Michigan LC-MS
ST000121 AN000203 Impact of anesthesia and euthanasia on metabolomics of mammalian tissues: studies in a C57BL/6J mouse model Muscle Mouse University of Michigan LC-MS
  logo